世界の不眠症治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Insomnia Therapeutics Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z07726 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥494,160 (USD3,480)	▷ お問い合わせ
Multi User	￥741,240 (USD5,220)	▷ お問い合わせ
Corporate User	￥988,320 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、不眠症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。不眠症治療薬の種類別市場規模（ベンゾジアゼピン系、非ベンゾジアゼピン系、抗うつ剤、オレキシン拮抗薬、メラトニン拮抗薬、その他）、用途別市場規模（処方箋、店頭（OTC））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・不眠症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Takeda Pharmaceutical Company Ltd.、Vanda Pharmaceuticals、Merck & Co., Inc.、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.、Mylan N.V.、Sumitomo Dainippon Pharma Co., Ltd、Sanofi、Paratek Pharmaceuticals Inc.、Ebb Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ベンゾジアゼピン系、非ベンゾジアゼピン系、抗うつ剤、オレキシン拮抗薬、メラトニン拮抗薬、その他 ・用途別分析2016年-2026年：処方箋、店頭（OTC） ・不眠症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・不眠症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・不眠症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・不眠症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・不眠症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Insomnia Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Insomnia Therapeutics Drugs size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Insomnia Therapeutics Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Insomnia Therapeutics Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others

Market segment by Application, can be divided into
Prescription
Over-the-Counter (OTC)

Market segment by players, this report covers
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Insomnia Therapeutics Drugs
1.2 Classification of Insomnia Therapeutics Drugs by Type
1.2.1 Overview: Global Insomnia Therapeutics Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Type in 2020
1.2.3 Benzodiazepines
1.2.4 Nonbenzodiazepines
1.2.5 Antidepressants
1.2.6 Orexin Antagonists
1.2.7 Melatonin Antagonists
1.2.8 Others
1.3 Global Insomnia Therapeutics Drugs Market by Application
1.3.1 Overview: Global Insomnia Therapeutics Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Global Insomnia Therapeutics Drugs Market Size & Forecast
1.5 Global Insomnia Therapeutics Drugs Market Size and Forecast by Region
1.5.1 Global Insomnia Therapeutics Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Insomnia Therapeutics Drugs Market Size by Region, (2016-2021)
1.5.3 North America Insomnia Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Insomnia Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Insomnia Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Insomnia Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Insomnia Therapeutics Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Insomnia Therapeutics Drugs Market Drivers
1.6.2 Insomnia Therapeutics Drugs Market Restraints
1.6.3 Insomnia Therapeutics Drugs Trends Analysis
2 Company Profiles
2.1 Takeda Pharmaceutical Company Ltd.
2.1.1 Takeda Pharmaceutical Company Ltd. Details
2.1.2 Takeda Pharmaceutical Company Ltd. Major Business
2.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product and Solutions
2.1.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
2.2 Vanda Pharmaceuticals
2.2.1 Vanda Pharmaceuticals Details
2.2.2 Vanda Pharmaceuticals Major Business
2.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product and Solutions
2.2.4 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Vanda Pharmaceuticals Recent Developments and Future Plans
2.3 Merck & Co., Inc.
2.3.1 Merck & Co., Inc. Details
2.3.2 Merck & Co., Inc. Major Business
2.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Product and Solutions
2.3.4 Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck & Co., Inc. Recent Developments and Future Plans
2.4 Pfizer Inc.
2.4.1 Pfizer Inc. Details
2.4.2 Pfizer Inc. Major Business
2.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Product and Solutions
2.4.4 Pfizer Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Inc. Recent Developments and Future Plans
2.5 Teva Pharmaceutical Industries Ltd.
2.5.1 Teva Pharmaceutical Industries Ltd. Details
2.5.2 Teva Pharmaceutical Industries Ltd. Major Business
2.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product and Solutions
2.5.4 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.6 Mylan N.V.
2.6.1 Mylan N.V. Details
2.6.2 Mylan N.V. Major Business
2.6.3 Mylan N.V. Insomnia Therapeutics Drugs Product and Solutions
2.6.4 Mylan N.V. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Mylan N.V. Recent Developments and Future Plans
2.7 Sumitomo Dainippon Pharma Co., Ltd
2.7.1 Sumitomo Dainippon Pharma Co., Ltd Details
2.7.2 Sumitomo Dainippon Pharma Co., Ltd Major Business
2.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product and Solutions
2.7.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Insomnia Therapeutics Drugs Product and Solutions
2.8.4 Sanofi Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Paratek Pharmaceuticals Inc.
2.9.1 Paratek Pharmaceuticals Inc. Details
2.9.2 Paratek Pharmaceuticals Inc. Major Business
2.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product and Solutions
2.9.4 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Paratek Pharmaceuticals Inc. Recent Developments and Future Plans
2.10 Ebb Therapeutics
2.10.1 Ebb Therapeutics Details
2.10.2 Ebb Therapeutics Major Business
2.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Product and Solutions
2.10.4 Ebb Therapeutics Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Ebb Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Insomnia Therapeutics Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Insomnia Therapeutics Drugs Players Market Share
3.2.2 Top 10 Insomnia Therapeutics Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Insomnia Therapeutics Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Insomnia Therapeutics Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Insomnia Therapeutics Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2016-2021)
5.2 Insomnia Therapeutics Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Insomnia Therapeutics Drugs Revenue by Type (2016-2026)
6.2 North America Insomnia Therapeutics Drugs Revenue by Application (2016-2026)
6.3 North America Insomnia Therapeutics Drugs Market Size by Country
6.3.1 North America Insomnia Therapeutics Drugs Revenue by Country (2016-2026)
6.3.2 United States Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Insomnia Therapeutics Drugs Revenue by Type (2016-2026)
7.2 Europe Insomnia Therapeutics Drugs Revenue by Application (2016-2026)
7.3 Europe Insomnia Therapeutics Drugs Market Size by Country
7.3.1 Europe Insomnia Therapeutics Drugs Revenue by Country (2016-2026)
7.3.2 Germany Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.3 France Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Insomnia Therapeutics Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Insomnia Therapeutics Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region
8.3.1 Asia-Pacific Insomnia Therapeutics Drugs Revenue by Region (2016-2026)
8.3.2 China Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.5 India Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Insomnia Therapeutics Drugs Revenue by Type (2016-2026)
9.2 South America Insomnia Therapeutics Drugs Revenue by Application (2016-2026)
9.3 South America Insomnia Therapeutics Drugs Market Size by Country
9.3.1 South America Insomnia Therapeutics Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Insomnia Therapeutics Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Insomnia Therapeutics Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country
10.3.1 Middle East & Africa Insomnia Therapeutics Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Insomnia Therapeutics Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Insomnia Therapeutics Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Insomnia Therapeutics Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Insomnia Therapeutics Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Insomnia Therapeutics Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Insomnia Therapeutics Drugs Revenue Market Share by Region (2021-2026)
Table 6. Takeda Pharmaceutical Company Ltd. Corporate Information, Head Office, and Major Competitors
Table 7. Takeda Pharmaceutical Company Ltd. Major Business
Table 8. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product and Solutions
Table 9. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Vanda Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 11. Vanda Pharmaceuticals Major Business
Table 12. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product and Solutions
Table 13. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck & Co., Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Merck & Co., Inc. Major Business
Table 16. Merck & Co., Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 17. Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Inc. Major Business
Table 20. Pfizer Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 21. Pfizer Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Teva Pharmaceutical Industries Ltd. Corporate Information, Head Office, and Major Competitors
Table 23. Teva Pharmaceutical Industries Ltd. Major Business
Table 24. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product and Solutions
Table 25. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Mylan N.V. Corporate Information, Head Office, and Major Competitors
Table 27. Mylan N.V. Major Business
Table 28. Mylan N.V. Insomnia Therapeutics Drugs Product and Solutions
Table 29. Mylan N.V. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Sumitomo Dainippon Pharma Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 31. Sumitomo Dainippon Pharma Co., Ltd Major Business
Table 32. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product and Solutions
Table 33. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sanofi Corporate Information, Head Office, and Major Competitors
Table 35. Sanofi Major Business
Table 36. Sanofi Insomnia Therapeutics Drugs Product and Solutions
Table 37. Sanofi Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Paratek Pharmaceuticals Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Paratek Pharmaceuticals Inc. Major Business
Table 40. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 41. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Ebb Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Ebb Therapeutics Major Business
Table 44. Ebb Therapeutics Insomnia Therapeutics Drugs Product and Solutions
Table 45. Ebb Therapeutics Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Insomnia Therapeutics Drugs Revenue (USD Million) by Players (2019-2021)
Table 47. Global Insomnia Therapeutics Drugs Revenue Share by Players (2019-2021)
Table 48. Breakdown of Insomnia Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Insomnia Therapeutics Drugs Players Head Office, Products and Services Provided
Table 50. Insomnia Therapeutics Drugs Mergers & Acquisitions in the Past Five Years
Table 51. Insomnia Therapeutics Drugs New Entrants and Expansion Plans
Table 52. Global Insomnia Therapeutics Drugs Revenue (USD Million) by Type (2016-2021)
Table 53. Global Insomnia Therapeutics Drugs Revenue Share by Type (2016-2021)
Table 54. Global Insomnia Therapeutics Drugs Revenue Forecast by Type (2021-2026)
Table 55. Global Insomnia Therapeutics Drugs Revenue by Application (2016-2021)
Table 56. Global Insomnia Therapeutics Drugs Revenue Forecast by Application (2021-2026)
Table 57. North America Insomnia Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Insomnia Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Insomnia Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Insomnia Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Insomnia Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Insomnia Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Insomnia Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Insomnia Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Insomnia Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Insomnia Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Insomnia Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Insomnia Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Insomnia Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Insomnia Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Insomnia Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Insomnia Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Insomnia Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Insomnia Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Insomnia Therapeutics Drugs Picture
Figure 2. Global Insomnia Therapeutics Drugs Revenue Market Share by Type in 2020
Figure 3. Benzodiazepines
Figure 4. Nonbenzodiazepines
Figure 5. Antidepressants
Figure 6. Orexin Antagonists
Figure 7. Melatonin Antagonists
Figure 8. Others
Figure 9. Insomnia Therapeutics Drugs Revenue Market Share by Application in 2020
Figure 10. Prescription Picture
Figure 11. Over-the-Counter (OTC) Picture
Figure 12. Global Insomnia Therapeutics Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Insomnia Therapeutics Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Insomnia Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 15. Global Insomnia Therapeutics Drugs Revenue Market Share by Region in 2020
Figure 16. North America Insomnia Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Insomnia Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Insomnia Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Insomnia Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Insomnia Therapeutics Drugs Market Drivers
Figure 21. Insomnia Therapeutics Drugs Market Restraints
Figure 22. Insomnia Therapeutics Drugs Market Trends
Figure 23. Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
Figure 24. Vanda Pharmaceuticals Recent Developments and Future Plans
Figure 25. Merck & Co., Inc. Recent Developments and Future Plans
Figure 26. Pfizer Inc. Recent Developments and Future Plans
Figure 27. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Figure 28. Mylan N.V. Recent Developments and Future Plans
Figure 29. Sumitomo Dainippon Pharma Co., Ltd Recent Developments and Future Plans
Figure 30. Sanofi Recent Developments and Future Plans
Figure 31. Paratek Pharmaceuticals Inc. Recent Developments and Future Plans
Figure 32. Ebb Therapeutics Recent Developments and Future Plans
Figure 34. Global Insomnia Therapeutics Drugs Revenue Share by Players in 2020
Figure 35. Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Insomnia Therapeutics Drugs Revenue Market Share in 2020
Figure 37. Global Top 10 Players Insomnia Therapeutics Drugs Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Insomnia Therapeutics Drugs Revenue Share by Type in 2020
Figure 40. Global Insomnia Therapeutics Drugs Market Share Forecast by Type (2021-2026)
Figure 41. Global Insomnia Therapeutics Drugs Revenue Share by Application in 2020
Figure 42. Global Insomnia Therapeutics Drugs Market Share Forecast by Application (2021-2026)
Figure 43. North America Insomnia Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 44. North America Insomnia Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 45. North America Insomnia Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 46. United States Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Insomnia Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 50. Europe Insomnia Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 51. Europe Insomnia Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 52. Germany Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Insomnia Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Insomnia Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Insomnia Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 60. China Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Insomnia Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 67. South America Insomnia Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America Insomnia Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Insomnia Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Insomnia Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Insomnia Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source

---